AstaReal Co

What AstaReal Co does

AstaReal Co., Ltd. is a Japan-headquartered producer of natural astaxanthin derived from Haematococcus pluvialis microalgae and the primary astaxanthin-focused subsidiary of Fuji Chemical Group. The company's research lineage traces to Uppsala University in 1988; it was commercially established in 1994 upon acquiring BioCaroten AB and achieved the world's first commercial-scale production of natural astaxanthin from Haematococcus pluvialis for human consumption. AstaReal operates a proprietary indoor bioreactor cultivation system that enables year-round, weather-independent production of high-purity astaxanthin, supported by more than 35 years of accumulated research and over 85 clinical studies substantiating safety and efficacy.

The product portfolio spans two channels. The bulk B2B ingredient business supplies dietary supplement, food and beverage, cosmetics, and pet nutrition manufacturers worldwide under the AstaReal® brand in oleoresin (5%, 10%), powder (4%), cold-water-soluble powder (2.5%), and water-soluble emulsion (1%) formats, plus a complementary LutaReal™ lutein emulsion. The retail business markets finished consumer supplements under sub-brands including AstaReal ACT, Astarism, AstaCare, AstaMed MYO, Astavita Sports, Astavita e, Akaimegumi, Astamate (pets), and Astaxin, distributed through approximately 4,500 medical institutions in Japan and direct channels. Production occurs at three facilities in Gustavsberg (Sweden), Moses Lake, Washington (USA), and Japan, with sales offices in Japan, the US, Sweden, Singapore, India, and Australia, complemented by a distributor network across Asia.

AstaReal monetizes through bulk ingredient sales (primary), branded retail supplements, and technology licensing and partnership arrangements. Bulk pricing is quote-based and not publicly disclosed. The company holds FDA GRAS status (2010), Non-GMO Project Verification, Halal, Kosher, GMP, ISO 9001, FSSC 22000, and NSF GMP certifications, and contributed to the U.S. Pharmacopeia monograph for natural astaxanthin. AstaReal is wholly owned by Fuji Chemical Group with no disclosed external institutional investment or public listing.

Name

AstaReal Co

Legal name

AstaReal Co., Ltd.

Website

https://astareal.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

AstaReal Co., Ltd. is a Japan-headquartered subsidiary of Fuji Chemical Group that produces natural astaxanthin from Haematococcus pluvialis microalgae using proprietary indoor bioreactor cultivation, supplying bulk B2B ingredients and branded retail supplements to global nutraceutical, food, cosmetics, and pet nutrition markets.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)

akta.pro secondary industries

Pigments & Colorants (Carotenoids, Canthaxanthin) (AFADALAJ), Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)

Keywords

• Natural astaxanthin
• Microalgae cultivation
• Nutraceutical ingredients
• Dietary supplements
• Functional food ingredients

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Bulk Ingredient Sales (B2B): AstaReal supplies natural astaxanthin as a raw material ingredient to dietary supplement, food & beverage, cosmetics, and pet nutrition manufacturers worldwide. This is the primary revenue stream.
2. Branded Retail Products: AstaReal markets finished consumer products under the AstaReal brand, including supplements sold through medical institutions and direct-to-consumer channels in Japan.
3. Licensing and Technology Partnerships: The company generates revenue through technology licensing arrangements and partnerships that leverage its proprietary production methods.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

AstaReal cultivates Haematococcus pluvialis microalgae using proprietary indoor bioreactor technology to produce natural astaxanthin, which it sells globally as standardized bulk B2B ingredients (oil, powder, cold-water-soluble powder, water-soluble emulsion, softgels) to dietary supplement, food and beverage, cosmetics, and pet nutrition manufacturers. It also markets a portfolio of branded finished products—including medical nutrition supplements, sports supplements, skincare serums, and pet supplements—sold through medical institutions in Japan, distributors in Europe and Asia, and the Astaxin brand in Europe and China.

Product overview

AstaReal Co is a global leader in natural astaxanthin products, offering a comprehensive portfolio spanning B2B bulk ingredients for manufacturers and B2C retail products for consumers. The bulk product line includes specialized astaxanthin formats: AstaReal® Oil (oleoresin in 5% and 10% concentrations), AstaReal® Powder (4% free-flowing powder), AstaReal® Cold Water Soluble Powder (2.5% CWS format), AstaReal® Water Soluble Emulsion (1% liquid format), LutaReal™ Water Soluble Emulsion (lutein complement), bulk softgel capsules, and Novasta® for Animal nutrition. The retail segment comprises medical nutrition products (AstaReal® ACT, Astarism® facial serum, AstaCare®, AstaMed MYO®) designed for healthcare professionals, and consumer care products (Astavita® Sports, Astavita® e, Akaimegumi, Astamate for pets, and Astaxin). All products are derived from the microalgae Haematococcus pluvialis with over 35 years of research backing and more than 85 clinical studies supporting efficacy and safety.

Differentiator

Problem solved

Functional benefit

Brands

• Astaxin: World's first human dietary supplement containing natural astaxanthin, available in Europe and China.
• Astavita®
• AstaMed
• Astarism®
• AstaCare®
• Novasta®
• LutaReal™

Products and services

• AstaReal® Oil (Oleoresin) Standardized 5% and 10% natural astaxanthin oleoresin extracted from Haematococcus pluvialis algal biomass using solvent-free supercritical CO2 extraction; sold as a B2B ingredient for softgel capsules and functional foods including chocolate and gummies.
• AstaReal® Powder Free-flowing 4% natural astaxanthin powder manufactured with spray-dry technology for heat resistance; supplied to B2B manufacturers for hard capsules, tablets, and functional foods.
• AstaReal® Cold Water Soluble Powder 2.5% cold-water-soluble (CWS) astaxanthin powder that dissolves in cold water within 30 seconds; taste-free, odor-free, with no oil ring formation. Supplied as a B2B ingredient for powder sachets, powder drinks, and functional foods.
• AstaReal® Water Soluble Emulsion 1% water-soluble astaxanthin emulsion with high transparency, clarity, and stability across a wide pH range; supplied as a B2B ingredient for ready-to-drink beverages and functional foods.
• LutaReal™ Water Soluble Emulsion 1% water-soluble lutein emulsion extracted from marigold flower, designed for ready-to-drink products with transparency and clarity; complements astaxanthin in combined health formulations.
• AstaReal® Bulk Softgel Capsules Ready-to-launch private-label softgel capsules containing AstaReal natural astaxanthin, supplied in bulk for manufacturer private-label needs.
• Novasta® for Animal High-performance feed ingredient containing natural astaxanthin whole-algae biomass; supplied to pet food and animal nutrition manufacturers for joint health and mobility support.
• AstaReal® ACT Science-based dietary supplement formulation for optimal health, distributed through approximately 4,500 medical institutions in Japan and additional countries.
• Astarism® Facial serum skin-conditioning product with high astaxanthin concentration designed for skin absorption; endorsed by dermatologists in Japan.
• AstaCare® Advanced dietary supplement combining astaxanthin, ubiquinol COQ10, vitamin D3, tocotrienol, and zinc, marketed for active and healthy lifestyles.
• AstaMed MYO® Medical nutrition dietary supplement originally formulated for the management of sarcopenia, with formulation developed in a joint study with the University of Washington.
• Astavita® Sports Athletic dietary supplement for professional and amateur athletes, endorsed by professional athletes in Japan and Informed Choice certified for anti-doping compliance.
• Astavita® e Daily-life dietary supplement designed to relieve mental and physical fatigue, classified as a 'Foods with Function Claims' product in Japan.
• Akaimegumi Whole-algae dietary supplement providing dietary fiber, unsaturated fatty acids, and minerals including calcium and iron, packaged as a consumer retail product.
• Astamate Pet dietary supplement backed by clinical study supporting muscle health and improved coat shine in companion animals.
• Astaxin World's first natural astaxanthin dietary supplement for healthy and energetic living, marketed under the Astaxin brand in Europe and China.
• Fuji Sakura (Natural Cherry Blossom Flower Extract) Natural cherry blossom flower extract ingredient designed for skin health and beauty-from-within formulations, supplied to B2B customers in the dietary supplement and functional food categories.

Quantifiable outcome

• More than 85 clinical studies supporting product efficacy
• +1 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• Barentz India Pvt. Ltd.coreChannel Partner/ Reseller/ DistributorBarentz India serves as a distributor for AstaReal products in the Indian market, participating at Vitafoods India 2026 to showcase and promote AstaReal natural astaxanthin ingredients to Indian manufacturers.
• GowellcoreChannel Partner/ Reseller/ DistributorGowell serves as a distributor for AstaReal products in Southeast Asia, showcasing products at Vitafoods Asia 2025.
• Primo Trading Co., Ltd.coreChannel Partner/ Reseller/ DistributorPrimo Trading serves as a distributor for AstaReal products, participating at Fi Asia trade show.
• Wei Ming Pharmaceutical TaiwancoreChannel Partner/ Reseller/ DistributorWei Ming Pharmaceutical is the exclusive distributor for AstaReal raw material in Taiwan, handling local distribution and sales of natural astaxanthin ingredients.
• Mindly Healthcare Hong KongcoreChannel Partner/ Reseller/ DistributorMindly Healthcare serves as the distribution partner for AstaReal in Hong Kong market.
• VicchiminorOthersVicchi was mentioned as showcasing concept samples alongside AstaReal products, suggesting a collaborative product development or co-marketing relationship.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Algatechnologies: Algatechnologies (Israel, now part of Solabia group) produces natural astaxanthin from Haematococcus pluvialis in closed-tube and photobioreactor systems. Directly competes in the B2B natural astaxanthin ingredient market with similar product formats.
• Cyanotech Corporation: Cyanotech (NASDAQ: CYAN) produces natural astaxanthin from Haematococcus pluvialis via open-pond cultivation in Hawaii. It is the most direct public competitor to AstaReal in natural astaxanthin bulk production, with overlapping B2B nutraceutical customer base.
• Algalif: Algalif (Iceland) produces high-potency natural astaxanthin from Haematococcus pluvialis using proprietary photobioreactor technology. Direct competitor in premium natural astaxanthin bulk supply for nutraceutical and cosmetic applications.
• BGG (Beijing Gingko Group): BGG produces natural astaxanthin (AstaZine®) along with other botanicals from its Haematococcus pluvialis operations in China. Direct competitor in natural astaxanthin bulk supply, particularly in Asian B2B markets.

Broad incumbents

• Kemin Industries: Kemin is a privately held ingredient manufacturer producing carotenoids and natural antioxidants for human and animal nutrition. Overlaps with AstaReal in supplying natural colorants and antioxidant ingredients to F&B and nutraceutical manufacturers.
• Lonza Group: Lonza is a global contract manufacturer and supplier of nutritional ingredients, including carotenoids and other bioactives. Overlaps with AstaReal at the B2B ingredient customer interface across dietary supplement and functional food manufacturers.
• dsm-firmenich: dsm-firmenich is a global ingredient major producing both synthetic carotenoids (incl. astaxanthin) and a broad portfolio of vitamins, nutraceuticals, and personal care actives. It competes broadly in the same customer RFPs as AstaReal, but at much greater scale and across many categories.
• BASF: BASF is one of the largest producers of synthetic astaxanthin (Lucantin®) for aquaculture and animal feed, and also operates a broad nutrition and health ingredients portfolio. Competes primarily on price in volume channels rather than directly in premium natural astaxanthin.

Emerging players

• ENZYMOTEC: Enzymotec (Israel) develops lipid-based bioactives and krill oil-derived astaxanthin products for the nutraceutical market. Partial overlap with AstaReal in the cognitive, eye-health, and heart-health ingredient space, particularly through phospholipid-formulated astaxanthin delivery.
• Piveg Inc. Piveg produces natural astaxanthin from Haematococcus pluvialis in Spain. A smaller, regional competitor with similar product positioning to AstaReal, primarily serving European nutraceutical and F&B manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCBQ10QGWuCzXkRRgRzX3Rvw
• LinkedInjp.linkedin.com/company/astareal-inc-
• Facebookfacebook.com/175933075776580

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AstaReal Co